Liver resection in patients with eight or more colorectal liver metastases

British Journal of Surgery

Volumn 102, Issue 1, 2015, Pages 92-101

  Vigano L ^a,b   Capussotti, L ^b   Majno, P ^c,d   Toso, C ^c,d   Ferrero, A ^b   De Rosa, G ^b   Rubbia Brandt, L ^c,d   Mentha, G ^c,d  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c University Hospitals   (Switzerland)

^d Hepato pancreato biliary Centre   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; COLORECTAL TUMOR; EPIDEMIOLOGY; FEMALE; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; PROCEDURES; SECONDARY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 84919372194     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9680     Document Type: Article

References (30)

1. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al.,. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231: 487-499.
2. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA,. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13: 1261-1268.
3. Aloia TA, Vauthey JN,. Management of colorectal liver metastases: past, present, and future. Updates Surg 2011; 63: 1-3.
4. Steele G Jr, Ravikumar TS,. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 1989; 210: 127-138.
5. Tanaka K, Adam R, Shimada H, Azoulay D, Lévi F, Bismuth H,. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003; 90: 963-969.
6. Smith MD, McCall JL,. Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases. Br J Surg 2009; 96: 1101-1113.
7. Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al.,. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012; 17: 1225-1239.
8. Rees M, Tekkis PP, Welsh FKS, O'Rourke T, John TG,. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
9. Padman S, Padbury R, Beeke C, Karapetis CS, Bishnoi S, Townsend AR, et al.,. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy. Acta Oncol 2013; 52: 1699-1706.
10. Malik HZ, Hamady ZZ, Adair R, Finch R, Al-Mukhtar A, Toogood GJ, et al.,. Prognostic influence of multiple hepatic metastases from colorectal cancer. Eur J Surg Oncol 2007; 33: 468-473.
11. Saiura A, Yamamoto J, Hasegawa K, Koga R, Sakamoto Y, Hata S, et al.,. Liver resection for multiple colorectal liver metastases with surgery up-front approach: bi-institutional analysis of 736 consecutive cases. World J Surg 2012; 36: 2171-2178.
12. Viganò L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L,. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol 2013; 20: 938-945.
13. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD,. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006; 93: 872-878.
14. Andres A, Majno PE, Morel P, Rubbia-Brandt L, Giostra E, Gervaz P, et al.,. Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol 2008; 15: 134-143.
15. Viganò L, Russolillo N, Ferrero A, Langella S, Sperti E, Capussotti L,. Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades. Ann Surg Oncol 2012; 19: 2035-2044.
16. Seium Y, Stupp R, Ruhstaller T, Gervaz P, Mentha G, Philippe M, et al.,. Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 2005; 16: 762-766.
17. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, et al.,. 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008; 25: 430-435.
18. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.,. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
19. Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, et al.,. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007; 18: 299-304.
20. Gerds TA, Kattan MW, Schumacher M, Yu C,. Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Stat Med 2013; 32: 2173-2184.
21. Efron B, Tibshirani RJ,. Improvements on cross-validation: the.632+ bootstrap method. J Am Stat Assoc 1997; 92: 548-560.
22. Combescure C, Perneger TV, Weber DC, Daurès JP, Foucher Y,. Prognostic ROC curves: a method for representing the overall discriminative capacity of binary markers with right-censored time-to-event endpoints. Epidemiology 2014; 25: 103-109.
23. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M,. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94: 982-999.
24. Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, et al.,. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 2007; 14: 1151-1160.
25. Kokudo N, Imamura H, Sugawara Y, Sakamoto Y, Yamamoto J, Seki M, et al.,. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004; 11: 84-91.
26. Shimada H, Tanaka K, Masui H, Nagano Y, Matsuo K, Kijima M, et al.,. Results of surgical treatment for multiple (> or =5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg 2004; 389: 114-121.
27. Weber SM, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y,. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7: 643-650.
28. Sakamoto Y, Fujita S, Akasu T, Nara S, Esaki M, Shimada K, et al.,. Is surgical resection justified for stage IV colorectal cancer patients having bilobar hepatic metastases? An analysis of survival of 77 patients undergoing hepatectomy. J Surg Oncol 2010; 102: 784-788.
29. Viganò L, Capussotti L, Barroso E, Nuzzo G, Laurent C, Ijzermans JN, et al.,. Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol 2012; 19: 2786-2796.
30. Wicherts DA, de Haas RJ, Salloum C, Andreani P, Pascal G, Sotirov D, et al.,. Repeat hepatectomy for recurrent colorectal metastases. Br J Surg 2013; 100: 808-818.